232 related articles for article (PubMed ID: 33870918)
1. Acute Cardiac Injury in Coronavirus Disease 2019 and Other Viral Infections-A Systematic Review and Meta-Analysis.
Cheng MP; Cau A; Lee TC; Brodie D; Slutsky A; Marshall J; Murthy S; Lee T; Singer J; Demir KK; Boyd J; Ohm H; Maslove D; Goffi A; Bogoch II; Sweet DD; Walley KR; Russell JA;
Crit Care Med; 2021 Sep; 49(9):1558-1566. PubMed ID: 33870918
[TBL] [Abstract][Full Text] [Related]
2. Acute Kidney Injury and Renal Replacement Therapy in COVID-19 Versus Other Respiratory Viruses: A Systematic Review and Meta-Analysis.
Cau A; Cheng MP; Lee T; Levin A; Lee TC; Vinh DC; Lamontagne F; Singer J; Walley KR; Murthy S; Patrick D; Rewa O; Winston B; Marshall J; Boyd J; Russell JA
Can J Kidney Health Dis; 2021; 8():20543581211052185. PubMed ID: 34733538
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2.
Ohishi T; Hishiki T; Baig MS; Rajpoot S; Saqib U; Takasaki T; Hara Y
PLoS One; 2022; 17(7):e0271112. PubMed ID: 35830431
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the Severe Acute Respiratory Syndrome Coronavirus-2 Receptor, Angiotensin-Converting Enzyme 2, in Diabetic Kidney Disease: Implications for Kidney Injury in Novel Coronavirus Disease 2019.
Gilbert RE; Caldwell L; Misra PS; Chan K; Burns KD; Wrana JL; Yuen DA
Can J Diabetes; 2021 Mar; 45(2):162-166.e1. PubMed ID: 32917504
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease.
Tomasoni D; Italia L; Adamo M; Inciardi RM; Lombardi CM; Solomon SD; Metra M
Eur J Heart Fail; 2020 Jun; 22(6):957-966. PubMed ID: 32412156
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-Associated Nonocclusive Fibrin Microthrombi in the Heart.
Bois MC; Boire NA; Layman AJ; Aubry MC; Alexander MP; Roden AC; Hagen CE; Quinton RA; Larsen C; Erben Y; Majumdar R; Jenkins SM; Kipp BR; Lin PT; Maleszewski JJ
Circulation; 2021 Jan; 143(3):230-243. PubMed ID: 33197204
[TBL] [Abstract][Full Text] [Related]
8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
9. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia.
Bloise E; Zhang J; Nakpu J; Hamada H; Dunk CE; Li S; Imperio GE; Nadeem L; Kibschull M; Lye P; Matthews SG; Lye SJ
Am J Obstet Gynecol; 2021 Mar; 224(3):298.e1-298.e8. PubMed ID: 32853537
[TBL] [Abstract][Full Text] [Related]
10. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.
Lopes RD; Macedo AVS; de Barros E Silva PGM; Moll-Bernardes RJ; Feldman A; D'Andréa Saba Arruda G; de Souza AS; de Albuquerque DC; Mazza L; Santos MF; Salvador NZ; Gibson CM; Granger CB; Alexander JH; de Souza OF;
Am Heart J; 2020 Aug; 226():49-59. PubMed ID: 32502882
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and Cardiovascular Disease.
Clerkin KJ; Fried JA; Raikhelkar J; Sayer G; Griffin JM; Masoumi A; Jain SS; Burkhoff D; Kumaraiah D; Rabbani L; Schwartz A; Uriel N
Circulation; 2020 May; 141(20):1648-1655. PubMed ID: 32200663
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
Edmonston DL; South AM; Sparks MA; Cohen JB
Adv Chronic Kidney Dis; 2020 Sep; 27(5):404-411. PubMed ID: 33308506
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-Converting Enzyme Gene Polymorphism and Severe Lung Injury in Patients with Coronavirus Disease 2019.
Zheng H; Cao JJ
Am J Pathol; 2020 Oct; 190(10):2013-2017. PubMed ID: 32735889
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019.
Siri-Angkul N; Chattipakorn SC; Chattipakorn N
J Physiol; 2020 Oct; 598(19):4181-4195. PubMed ID: 32710575
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and treatments of myocardial injury in patients with corona virus disease 2019.
Peng W; Wu H; Tan Y; Li M; Yang D; Li S
Life Sci; 2020 Dec; 262():118496. PubMed ID: 32987060
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.
Suh SH; Ma SK; Kim SW; Bae EH
Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712
[TBL] [Abstract][Full Text] [Related]
18. Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics.
Rezkalla SH; Kloner RA
Trends Cardiovasc Med; 2021 Apr; 31(3):163-169. PubMed ID: 33383171
[TBL] [Abstract][Full Text] [Related]
19. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
20. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
Malek Mahdavi A
Rev Med Virol; 2020 Sep; 30(5):e2119. PubMed ID: 32584474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
